Interleukin-6 and insulin-like growth factor-1 synergistically promote the progression of NSCLC

• Váldodahkkit: Hexiao Tang (Dahkki), Yuquan Bai (Dahkki), Gaofeng Pan (Dahkki), Xianguo Wang (Dahkki), Yanhong Wei (Dahkki), Zetian Yang (Dahkki), Jinping Zhao (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2018-11-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

The signaling pathways of interleukin-6 (IL-6) and insulin-like growth factor 1 (IGF-1) play an important role in the progression of lung cancer, and this study aimed to explore whether they can synergistically promote the progression of non-small cell lung cancer (NSCLC). We found that IL-6, glycop...